Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sapu003 in Advanced mTOR-sensitive Solid TumorsCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Malformations of Cortical Development, Group I, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Multiple Primary, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, central nervous system malformation, cerebral cortical dysplasia, epithelial neoplasm, hamartoma, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, kidney cancer, kidney disorder, liver disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuroendocrine neoplasm, primitive neuroectodermal tumor, renal cell carcinoma, tuberous sclerosis, urinary system disorderRecruitingPhase 12026-01-27NCT07369505

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
SAPU NANO (US) LLC1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
SOCRUAdelaideAustralia1